Believe it or not, there is a beneficiary of the controversial decision by Susan G. Komen for the Cure to not continue funding breast cancer screening at Planned Parenthood centers.
San Francisco-based Breast Cancer Action saw donations from its recent email alerts surge 30-fold from the average volume of click-throughs from the alerts, said spokeswoman Angela Wall. It sent out two alerts Wednesday about the change in Komen’s grant process, which Planned Parenthood has charged was based on pressure from antiabortion activists, and how the change affects Planned Parenthood.
“That’s huge for us,” Wall said about the surge in email alert responses.
No comments:
Post a Comment